SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-21-062770
Filing Date
2021-12-01
Accepted
2021-12-01 12:24:22
Documents
14
Period of Report
2021-07-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM 10-K f10k2021a2_enzobiochem.htm   iXBRL 10-K/A 270193
2 CERTIFICATION f10k2021a2ex31-1_enzobio.htm EX-31.1 8072
3 CERTIFICATION f10k2021a2ex31-2_enzobio.htm EX-31.2 8253
  Complete submission text file 0001213900-21-062770.txt   532647

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE enz-20210731.xsd EX-101.SCH 3000
5 XBRL LABEL FILE enz-20210731_lab.xml EX-101.LAB 34230
6 XBRL PRESENTATION FILE enz-20210731_pre.xml EX-101.PRE 22340
7 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021a2_enzobiochem_htm.xml XML 6836
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-K/A | Act: 34 | File No.: 001-09974 | Film No.: 211462053
SIC: 8071 Services-Medical Laboratories